Cytokinetics Inc (CYTK)
44.57
-2.00
(-4.29%)
USD |
NASDAQ |
Mar 25, 16:00
45.10
+0.53
(+1.19%)
After-Hours: 18:23
Cytokinetics Enterprise Value: 5.095B for March 24, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Biogen Inc | 24.65B |
| Sage Therapeutics Inc | 0.3402M |
| Akero Therapeutics Inc | 2.881B |
| Bristol-Myers Squibb Co | 162.73B |
| Rhythm Pharmaceuticals Inc | 3.219B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -150.02M |
| Revenue (Quarterly) | 16.93M |
| Total Expenses (Quarterly) | 155.97M |
| EPS Diluted (Quarterly) | -1.26 |
| Gross Profit Margin (Quarterly) | -453.1% |
| Profit Margin (Quarterly) | -886.3% |
| Earnings Yield | -11.80% |
| Normalized Earnings Yield | -11.83 |